Post by GSK

Name: #News for #Media and #Investors: Today we announced interim positive headline results from our phase
Uploaded: 2026-07-13T06:06:27.194Z
Channel: GSK
Description: #News for #Media and #Investors: Today we announced interim positive headline results from our phase II registrational trial evaluating one of our immuno-oncology therapies. We look forward to sharing

4,830,015 followers

#News for #Media and #Investors: Today we announced interim positive headline results from our phase II registrational trial evaluating one of our immuno-oncology therapies. We look forward to sharing the full results later this year. Learn more: https://gsk.to/4vsrpML

Video Content